FFA1 (GPR40) AS A THERAPEUTIC TARGET FOR NEURAL ANGIOGENESIS DISEASES OR DISORDERS

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP17753944.2

公开号：

EP3416726A1

申请日:

2017.02.17

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

The present invention provide the discovery free-fat acid acceptor 1 (FFA1) of relevant method and composition a kind of as therapeutic target the neuron for treating or preventing disease or illness be characterized in that the retinosis of the eyes of angiogenesis or angiosis and/or tumour more generally. Treatment and/or prevention and known FFA1 inhibitor composition, the reagent including small molecule and nucleic acid, description. FFA1 inhibitor for identifying new is also provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/